This Is MS Multiple Sclerosis Knowledge & Support Community

A clinical trial is starting in UK also. Now, after reviewing published data on drug treatments that might help protect nerves in the brain, UK researchers are focusing on three drugs that are licensed for other conditions. From BBC News "MS hope from 'off-the-shelf' drugs" About 500 people with lat...

A clinical trial now underway at Queen Mary University in London, England, called be INSPIRE trial (click here), is attempting to use Raltegravir to treat MS patients. Researchers hope that the drug will deactivate any activated retroviral material in the DNA of MS patients, while perhaps also comba...

This is the same (or very similar to) procedure that Dr. Burt is doing at Northwestern University. And there is a lot of discussion under the "stem cell" section. In the procedure, Burt and colleagues treated patients with chemotherapy to destroy their immune system. They then injected the patients ...

Please refer to this study by its ClinicalTrials.gov identifier: NCT00273364

Contacts
Contact: Dzemila Spahovic, MD 312-908-0059 d-spahovic@northwestern.edu


Here is contact info. contact me privately if you want.

http://clinicaltrials.gov/ct2/show/NCT0 ... ell&rank=2


This is the trial at Northwestern with Dr. Burt. It is worth investigating!

Opexa Therapeutics Inc. (OPXA) granted an exclusive license option to Germany-based Merck KGaA's (MKGAY, MRK.XE) biopharmaceutical division for the development and commercialization of Opexa's lead product candidate, Tcelna, for multiple sclerosis in a deal potentially valued at $225 million They mu...

RE: http://en.trend.az/regions/iran/2108864.html Some good points..... The study , per the web page description, has several problems which make it rather weak: 1. Only 65 patients finished the study. ( very small sample) 2. Duration of the study was okay ( 1 year, so we do not know what will happen...

I have a friend that is a Dr. and she also happens to also be from Iran. I sent her the article and she is going to look into it for me.

Thanks!

ScienceDaily (Nov. 27, 2012) — High-resolution real-time images show in mice how nerves may be damaged during the earliest stages of multiple sclerosis. The results suggest that the critical step happens when fibrinogen, a blood-clotting protein, leaks into the central nervous system and activates i...

New theory? "blocking fibrinogen's blood clotting activity prevented microglial activation and nerve damage". Wondering if this can already be done with a current drug? Dr. Akassoglou has focused on the role of the blood-brain barrier leak in MS and has discovered that leakage of the blood clotting ...

http://www.eurekalert.org/pub_releases/2012-11/nu-bnh111312.php I guess this is just getting picked up by national media. Looks like phase 2 is only recruiting newly diagnosed: "A phase 2 trial will explore how effective the therapy is in newly diagnosed patients, and will expand the sample size for...

Looks like they at least have locations and some are even recruiting:

http://clinicaltrials.gov/ct2/show/NCT0 ... exa&rank=3

Drug previously know as "Tovaxin". Sounds like some patients have already been enrolled, and they are expecting to enroll more SPMS patients. I hope it turns out to be as promising as it sounds. http://finance.yahoo.com/news/opexa-initiates-stage-clinical-study-110500862.html http://www.opexatherape...

My neuro asked me to point to where I thought the lesions on my spine were. I could tell exactly where both of them were. I never gave it that much thought....maybe that is not the norm?